Global Cardiovascular Prosthetic Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cardiovascular Prosthetic Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Cardiovascular Prosthetic Products are implantable or external devices that replace or assist parts of the cardiovascular system, such as the heart, arteries, or veins. Examples of cardiovascular prosthetic devices include pacemakers, implanted heart valves, artificial vascular grafts, and stents. These devices significantly improve quality of life and are normally installed by a heart surgeon. They are also used to treat a number of cardiac conditions, including valvular heart disease, congenital heart defects, arrhythmias, coronary artery disease, and heart failure. Aortic aneurysm repair, valve replacement, endovascular stenting, ventricular assist devices, transcatheter aortic valve replacement (TAVR), and other procedures all involve these cardiovascular prosthetic devices.

According to our (Global Info Research) latest study, the global Cardiovascular Prosthetic Products market size was valued at US$ 27880 million in 2023 and is forecast to a readjusted size of USD 49160 million by 2030 with a CAGR of 8.4% during review period.

According to report shared by Center for Disease Control and Prevention (CDC), in 2020, it was stated that, coronary heart disease is the most common type of heart disease, killing 382,820 people in U.S. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) happen in adults less than 65 years old. Increase in number of cardiovascular surgeries is anticipated to drive the application of cardiovascular prosthetic devices and boosts market growth. For instance, according to National Library of Medicine in September 2022, it was reported that, more than 200,000 heart valve replacement surgeries are performed annually worldwide, with a predicted increment to 8,50,000 per year by 2050. In addition, according to National Library of Medicine in August 2022, almost 400,000 coronary artery bypass grafting (CABG) surgeries are performed each year making it the most-performed major surgical procedure.

This report is a detailed and comprehensive analysis for global Cardiovascular Prosthetic Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Cardiovascular Prosthetic Products market size and forecasts, in consumption value ($ Million), 2019-2030

Global Cardiovascular Prosthetic Products market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Cardiovascular Prosthetic Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Cardiovascular Prosthetic Products market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Cardiovascular Prosthetic Products

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Cardiovascular Prosthetic Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Biotronic, W. L. Gore & Associates, Inc, Artivion, Inc, Johnson and Johnson, Medtronic Plc, Meril Life Sciences Pvt. Ltd, Edwards Lifesciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Cardiovascular Prosthetic Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Cardiovascular Prosthetic Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Cardiac Prosthetic Products
Vascular Prosthetic Products

Market segment by Application
Hospitals
Clinics
Others

Market segment by players, this report covers
Abbott Laboratories
B Braun Melsungen AG
Boston Scientific Corporation
Biotronic
W. L. Gore & Associates, Inc
Artivion, Inc
Johnson and Johnson
Medtronic Plc
Meril Life Sciences Pvt. Ltd
Edwards Lifesciences
Terumo Group
Maquet Cardiovascular
Gore
Nicast
Bard
Jude Medical
LeMaitre Vascular
Lifetech Scientific
BiVACOR
SynCardia
Jarvik Heart, Inc
CARMAT
AbioMed

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Cardiovascular Prosthetic Products product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Cardiovascular Prosthetic Products, with revenue, gross margin, and global market share of Cardiovascular Prosthetic Products from 2019 to 2024.

Chapter 3, the Cardiovascular Prosthetic Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cardiovascular Prosthetic Products market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiovascular Prosthetic Products.

Chapter 13, to describe Cardiovascular Prosthetic Products research findings and conclusion.